Abstract
Purpose
To compare the risk of developing subsequent primary lung cancer among cervical cancer patients and the general population.
Methods
Several databases were searched from inception to April 25, 2023. The standard incidence ratios (SIRs) with 95% confidence intervals (CIs) were combined to identify the risk for second primary lung cancer after cervical carcinoma. Subgroup analyses based on the follow-up period, age, degree of malignancy and source of SIR were conducted. All the statistical analyses were performed with STATA 15.0 software.
Results
A total of 22 retrospective studies involving 864,627 participants were included. The pooled results demonstrated that cervical cancer patients had a significantly greater risk for lung cancer than did the general population (SIR = 2.63, 95% CI: 2.37–2.91, P<0.001). Furthermore, subgroup analyses stratified by follow-up period (<5 years and ≥5 years), age (≤50 years and <50 years), and degree of malignancy (invasive and in situ) also revealed an increased risk of developing lung cancer among cervical carcinoma patients.
Conclusion
Cervical cancer patients are more likely to develop subsequent primary lung cancer than the general population, regardless of age, follow-up time or degree of malignancy. However, more high-quality prospective studies are still needed to verify our findings.
Funder
Chengdu High-level Key Clinical Specialty Construction Project
Publisher
Public Library of Science (PLoS)
Reference55 articles.
1. Cancer statistics, 2022;RL Siegel;CA: a cancer journal for clinicians,2022
2. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands;M Rebolj;International journal of cancer,2007
3. Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?;IM de Kok;International journal of cancer,2011
4. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019;MJ Kang;Cancer research and treatment,2022
5. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;C Xia;Chin Med J (Engl),2022